BREAKING
Home » Posts Tagged "Candida"

Vaginal Yeast Infections treatment, Oral Ibrexafungerp, receives FDA Acceptance and Priority Review of New Drug Application

By

SCYNEXIS, Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the U.S. Food and Drug Administration...

Cidara announces new data from IDWeek 2020

By

Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced...

Candida: NDA submitted to the FDA for antifungal drug representing a new class in over 20 years

By

Biotechnology company, SCYNEXIS, Inc. today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for oral ibrexafungerp for the treatment of vulvovaginal...

Battling Candida albicans with early detection

By

Researchers at Monash University have gained insights into how nanoparticles could be used to identify the presence of invasive and sometimes deadly microbes, and deliver targeted treatments more effectively. This...

Candida auris actively shed in the healthcare environment

By

Researchers have now shown that patients who are heavily colonized with Candida auris on their skin can shed the fungus and contaminate their surroundings. This finding provides an explanation for the...

Candidiasis: 138 million women suffer from fungal infection

By

Around 138 million women are affected by a distressing but treatable fungal infection world-wide, according to a research review by University of Manchester scientists. And the incidence of recurrent...

Vulvovaginal candidiasis treatment granted FDA QIDP and Fast Track designations

By

New Jersey based biotechnology company, SCYNEXIS, Inc. announced this week that the U.S. Food and Drug Administration(FDA) has granted both Qualified Infectious Disease Product (QIDP) and Fast Track...

Diagnosing and treating invasive fungal infections: New insights published

By

Thousands of patients suffering from invasive fungal infections in intensive-care units or after organ transplantation will benefit from the latest insights into diagnostic and therapeutic interventions,...

Intestinal fungi linked to worsening of alcoholic liver disease

By

A new study funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is among the first to suggest that intestinal fungi may contribute to the development of alcoholic liver disease (ALD)....

LA BioMed awarded NIH grant to develop vaccines against MRSA, Candida

By

The National Institutes of Health (NIH) recently awarded the first year of funding from a four-year, $1.3 million grant to the Los Angeles Biomedical Research Institute (LA BioMed) to aid in the research...